Within early and late stage groups, patients with low ALDH7A1 expression showed worse survival outcome: 5-year survival probability for the patients with late stage cancer and high ALDH7A1 expression was ~ 40% vs ~ 20% for patients with low ALDH7A1 (Fig. 2i). This evidence concerns the gene ALDH7A1 and cancer.